Literature DB >> 22506890

Coexisting adult polyglucosan body disease with frontotemporal lobar degeneration with transactivation response DNA-binding protein-43 (TDP-43)-positive neuronal inclusions.

Jill G Farmer1, Barbara J Crain, Brent T Harris, R Scott Turner.   

Abstract

Frontotemporal lobar degeneration with ubiquitin-positive inclusions (FTLD-U) is one of the most common pathological findings associated with the clinical FTLD syndromes. However, molecular characterization with genetic sequencing and protein expression techniques are recognizing many new subtypes for FTLDs. FTLDs are diverse and new nomenclature schemes have been proposed based on the molecular defects that are being discovered ( Mackenzie et al., 2010 , Acta Neuropathologica, 119, 1). Adult polyglucosan body disease (APBD) is a very rare disorder associated with systemic neurological signs and symptoms including progressive dementia with executive dysfunction and motor neuron disease. We report the clinical course of an individual with a clinical FTLD and the as yet unreported findings of coexistent APBD with FTLD-U and transactivation response DNA-binding protein-43 (TDP-43)-positive inclusions at autopsy (or more accurately, FTLD-TDP). It is unclear if these distinct findings are coincidental in this individual, or if pathogenic pathways may intersect to promote these coexisting pathologies.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22506890      PMCID: PMC3436935          DOI: 10.1080/13554794.2011.654217

Source DB:  PubMed          Journal:  Neurocase        ISSN: 1355-4794            Impact factor:   0.881


  9 in total

1.  Extensive white-matter changes in case of adult polyglucosan body disease.

Authors:  M Berkhoff; J Weis; G Schroth; M Sturzenegger
Journal:  Neuroradiology       Date:  2001-03       Impact factor: 2.804

Review 2.  TAR DNA-binding protein 43 in neurodegenerative disease.

Authors:  Alice S Chen-Plotkin; Virginia M-Y Lee; John Q Trojanowski
Journal:  Nat Rev Neurol       Date:  2010-03-16       Impact factor: 42.937

3.  Adult polyglucosan body disease.

Authors:  P Milde; J G Guccion; J Kelly; E Locatelli; R V Jones
Journal:  Arch Pathol Lab Med       Date:  2001-04       Impact factor: 5.534

4.  Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration.

Authors:  Nigel J Cairns; Eileen H Bigio; Ian R A Mackenzie; Manuela Neumann; Virginia M-Y Lee; Kimmo J Hatanpaa; Charles L White; Julie A Schneider; Lea Tenenholz Grinberg; Glenda Halliday; Charles Duyckaerts; James S Lowe; Ida E Holm; Markus Tolnay; Koichi Okamoto; Hideaki Yokoo; Shigeo Murayama; John Woulfe; David G Munoz; Dennis W Dickson; Paul G Ince; John Q Trojanowski; David M A Mann
Journal:  Acta Neuropathol       Date:  2007-06-20       Impact factor: 17.088

5.  Adult polyglucosan body disease: a postmortem correlation study.

Authors:  E Sindern; F Ziemssen; T Ziemssen; T Podskarbi; Y Shin; F Brasch; K M Müller; J M Schröder; J-P Malin; M Vorgerd
Journal:  Neurology       Date:  2003-07-22       Impact factor: 9.910

6.  TDP-43 in familial and sporadic frontotemporal lobar degeneration with ubiquitin inclusions.

Authors:  Nigel J Cairns; Manuela Neumann; Eileen H Bigio; Ida E Holm; Dirk Troost; Kimmo J Hatanpaa; Chan Foong; Charles L White; Julie A Schneider; Hans A Kretzschmar; Deborah Carter; Lisa Taylor-Reinwald; Katherine Paulsmeyer; Jeffrey Strider; Michael Gitcho; Alison M Goate; John C Morris; Manjari Mishra; Linda K Kwong; Anna Stieber; Yan Xu; Mark S Forman; John Q Trojanowski; Virginia M-Y Lee; Ian R A Mackenzie
Journal:  Am J Pathol       Date:  2007-07       Impact factor: 4.307

7.  Dementia of frontal lobe type due to adult polyglucosan body disease.

Authors:  P Boulan-Predseil; A Vital; B Brochet; D Darriet; P Henry; C Vital
Journal:  J Neurol       Date:  1995-08       Impact factor: 4.849

8.  Ubiquitinated pathological lesions in frontotemporal lobar degeneration contain the TAR DNA-binding protein, TDP-43.

Authors:  Yvonne Davidson; Thomas Kelley; Ian R A Mackenzie; Stuart Pickering-Brown; Daniel Du Plessis; David Neary; Julie S Snowden; David M A Mann
Journal:  Acta Neuropathol       Date:  2007-01-12       Impact factor: 17.088

9.  Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update.

Authors:  Ian R A Mackenzie; Manuela Neumann; Eileen H Bigio; Nigel J Cairns; Irina Alafuzoff; Jillian Kril; Gabor G Kovacs; Bernardino Ghetti; Glenda Halliday; Ida E Holm; Paul G Ince; Wouter Kamphorst; Tamas Revesz; Annemieke J M Rozemuller; Samir Kumar-Singh; Haruhiko Akiyama; Atik Baborie; Salvatore Spina; Dennis W Dickson; John Q Trojanowski; David M A Mann
Journal:  Acta Neuropathol       Date:  2009-11-19       Impact factor: 17.088

  9 in total
  3 in total

Review 1.  Frontotemporal dementia: a bridge between dementia and neuromuscular disease.

Authors:  Adeline S L Ng; Rosa Rademakers; Bruce L Miller
Journal:  Ann N Y Acad Sci       Date:  2014-12-30       Impact factor: 5.691

2.  Adult polyglucosan body disease with GBE1 haploinsufficiency and concomitant frontotemporal lobar degeneration.

Authors:  Esther N Bit-Ivan; Kyung-Hwa Lee; Darren Gitelman; Sandra Weintraub; Marsel Mesulam; Rosa Rademakers; Adrian M Isaacs; Kimmo J Hatanpaa; Charles L White; Qinwen Mao; Orhan Akman; Salvatore DiMauro; Eileen H Bigio
Journal:  Neuropathol Appl Neurobiol       Date:  2014-10       Impact factor: 8.090

Review 3.  Characterization of cognitive impairment in adult polyglucosan body disease.

Authors:  Paul Theo Zebhauser; Isabell Cordts; Holger Hengel; Bernhard Haslinger; Paul Lingor; Hasan Orhan Akman; Tobias B Haack; Marcus Deschauer
Journal:  J Neurol       Date:  2022-01-08       Impact factor: 6.682

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.